Sessions
Unlocking the Potential of Advanced Therapies Through Collaborations
Technology, Disruptive Innovation and Partnerships that are Revolutionizing How Medicines Are Made
Overcoming Scale Up Process Development Challenges for Pluripotent Stem Cell Derived Therapies
Future-Proofing Cell Therapy Production
Add It Up: 3 Things to Consider for Capacity Expansion
Why So Shy? Implementing Disruptive Technologies with Confidence in Cell Therapy
Unlocking the Potential of Advanced Therapies Through Collaborations
26 Jan 2022
12:30
Briefing Room
SPONSORED BY
What will be discussed:
- Top challenges faced by drug developers in academia and biotech
- Lessons learnt from translating innovation into therapies
- How different stakeholders can work together to advance life changing therapies into the market
Moderator
Delara Motlagh, General Manager, Cell Therapy Technologies, Terumo BCT
Panellists
Alex Klarer, Head of Cell Therapy, BioCentriq
Tifany Rau, Owner and Principal Consultant, Rau Consulting
Krishendu Roy, Robert A. Milton Chair Professor, Director, NSF ERC on Cell Manufacturing Technologies (CMaT), Georgia Tech (Live Streamed)
Speakers
Krishendu Roy
Robert A. Milton Chair Professor, Director, NSF ERC on Cell Manufacturing Technologies (CMaT)
